BAC provided highly technical services and products to pharmaceutical companies as they take new drugs through the FDA approval process. These services improve the yield and lower the cost to producers of new drugs, thereby improving their margins.
BAC’s products are taken to market directly and via partners such as GE Healthcare. The investment was a minority equity stake and made alongside Unilever Ventures. The investment was realised successfully in 2013 via sale to a US trade acquirer.
Team
Partner
Dan Walker